TardiMed Sciences LLC, 10% Owner at Timber Pharmaceuticals, Inc. (TMBR), sold 114,021 shares at $1.27 ($145K) on 2021-05-28, disclosed to the SEC on 2021-06-02.
Open-market sale of $145k TMBR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.27 | 47,736 | $61K | 41.9% |
| 2 | $1.27 | 47,736 | $61K | 41.9% |
| 3 | $1.26 | 8,670 | $11K | 7.6% |
| 4 | $1.26 | 9,879 | $12K | 8.6% |
| Total | $1.27 avg | 114,021 | $145K | 100% |
| Filing → |
| TMBR | SELL | 2021-09-01 | $368K | — | Filing → |
| TMBR | SELL | 2021-08-26 | $276K | — | Filing → |
| TMBR | SELL | 2021-08-20 | $168K | — | Filing → |